Education
About Us
Working with TipRanks
Follow Us
Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.20M | $ 4.98M | $ 5.65M | $ 4.31M | $ 5.56M |
| Gross Profit | $ -4.50K | $ 680.80K | $ 1.32M | $ -2.88M | $ 1.58M |
| Operating Income | $ -11.30M | $ -17.94M | $ -22.66M | $ -11.30M | $ -1.50M |
| EBITDA | $ -11.30M | $ -13.84M | $ -22.66M | $ -11.16M | $ -10.02M |
| Net Income | $ -13.42M | $ -21.03M | $ -17.90M | $ -20.42M | $ -1.79M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 401.80K | $ 7.03M | $ 17.54M | $ 23.98M | $ 153.12K |
| Total Assets | $ 2.03M | $ 19.08M | $ 22.84M | $ 29.13M | $ 3.72M |
| Total Debt | $ 1.30M | $ 2.71M | $ 1.68M | $ 375.56K | $ 2.22M |
| Net Debt | $ 897.41K | $ -4.33M | $ -15.86M | $ -23.60M | $ 2.07M |
| Total Liabilities | $ 4.14M | $ 10.32M | $ 6.27M | $ 10.83M | $ 5.65M |
| Stockholders' Equity | $ -2.10M | $ 7.24M | $ 16.56M | $ 18.29M | $ -1.93M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.30M | $ -13.57M | $ -14.87M | $ -9.97M | $ -137.15K |
| Operating Cash Flow | $ -10.30M | $ -13.25M | $ -14.73M | $ -9.76M | $ 57.33K |
| Investing Cash Flow | $ 4.22M | $ -183.76K | $ -141.36K | $ -160.56K | $ -194.48K |
| Financing Cash Flow | $ -550.00K | $ 2.91M | $ 8.43M | $ 33.76M | $ 165.14K |
Qualigen Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.